SV2A and anxiety disorder: SV2A is the binding site of the anticonvulsant drug levetiracetam ((S)-α-Ethyl-2-oxo-1-pyrrolidineacetamide)52, which has shown promise in anxiety disorder treatment63–69, but also generates states of anxiety as a side-effect in some individuals70,71.